7:33AM Tianyin Pharma Receives Production License for Its Anti-diabetic Drug Gliclazide Tablets from China's SFDA (TPI) 1.72 : Co announces it has received the production license for its anti-diabetic drug Gliclazide Tablets from China's State Food and Drug Administration. The national pharmaceutical certificate number for TPI's new Gliclazide Tablets is also issued: H20113233.